T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 03/31/2016
Volatility and Other Measures
as of 03/31/2016
Beta 0.93
Standard Deviation 16.94
Price/Earnings Ratio (Domestic) 19.0
Earnings Growth Rate (Domestic) 11.9
Turnover Rate 4.5
Median Market
$32,157.98 Million
Sector Diversification
as of 03/31/2016
% of Total Net Assets
Services 36.2%
Biotechnology 24.9%
Pharmaceuticals 20.6%
Products & Devices 10.6%
Life Sciences 6.4%
10 Largest Holdings
Represents 38.32 % of Total Net Assets
View Holdings as of:
Alexion Pharmaceuticals
Becton, Dickinson & Company
Bristol-Myers Squibb
Gilead Sciences
Thermo Fisher Scientific
UnitedHealth Group
As of 03/31/2016 the Health Sciences Fund had a total of 137 holdings.
See Glossary for additional details on all data elements.